We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of an Ankle-Foot Orthosis on Gait While Performing an Attention Demanding Task

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01320839
Recruitment Status : Completed
First Posted : March 23, 2011
Last Update Posted : March 7, 2014
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
We hypothesize that: (1) gait stability will be increased when wearing an ankle-foot orthosis (plastic brace supporting the foot and ankle); (2) an attention demanding task will decrease gait stability and (3) the improvement in gait stability due to ankle-foot orthosis use will be greater during an attention demanding task.

Condition or disease
Stroke Gait, Hemiplegic

Detailed Description:
A quasi-experimental, randomized 2 x 2 factorial within subjects study with the factor of walking condition (2 levels, walking with and without ankle-foot orthotic device) and attention condition (2 levels, walking with and without attention task).

Study Design

Study Type : Observational
Actual Enrollment : 21 participants
Observational Model: Case-Crossover
Time Perspective: Cross-Sectional
Official Title: Effects of an Ankle-Foot Orthosis on Gait While Performing an Attention Demanding Task in People With Poststroke Hemiplegia
Study Start Date : March 2011
Primary Completion Date : November 2013
Study Completion Date : November 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Foot Health
U.S. FDA Resources

Groups and Cohorts

Group/Cohort
Stroke
People who have had a stroke and have an ankle-foot orthosis.


Outcome Measures

Primary Outcome Measures :
  1. Velocity [ Time Frame: up to one week ]
    walking velocity


Secondary Outcome Measures :
  1. trunk acceleration [ Time Frame: up to one week ]
    trunk acceleration during walking

  2. Step length variability [ Time Frame: up to one week ]
    variability of right and left step length during walking

  3. The Berg Balance Scale [ Time Frame: up to one week ]
    Functional balance measured using the Berg Balance Scale short form.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People who have had a hemiplegic stroke and have an ankle-foot orthosis.
Criteria

Inclusion Criteria:

  • be over the age of 18;
  • have the presence of hemiplegia after stroke;
  • be wearing an ankle-foot orthosis for at least 6 weeks;
  • be able to walk independently and comfortably for a minimum distance of 12 m with or without assistive aids (AFOs, canes and walkers);
  • be able to read and understand English, follow verbal instructions and provide verbal answers to questions;
  • be able to reach criterion on the attention task (described below)
  • be competent to give informed consent as determined by clinical team and noted in the health chart

Exclusion Criteria:

  • have history of balance deficits not related to stroke;
  • be at high risk of falling during the study;
  • suffer from severe aphasia or dementia as determined by health chart and/or initial cognitive screening using the Montreal Cognitive Assessment (MoCA) test.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01320839


Locations
Canada, Nova Scotia
Capital Health
Halifax, Nova Scotia, Canada, B3H 4K4
Sponsors and Collaborators
Nova Scotia Health Authority
Investigators
Principal Investigator: Kim Parker, M.A.Sc. CDHA
More Information

Responsible Party: Kim Parker, Rehabilitation Engineer, Capital District Health Authority, Canada
ClinicalTrials.gov Identifier: NCT01320839     History of Changes
Other Study ID Numbers: CDHA-RS/2011-004
First Posted: March 23, 2011    Key Record Dates
Last Update Posted: March 7, 2014
Last Verified: March 2014

Additional relevant MeSH terms:
Gait Disorders, Neurologic
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms